Literature DB >> 17980177

Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes.

Adam J Duhl1, Michael J Paidas, Serdar H Ural, Ware Branch, Holly Casele, Joan Cox-Gill, Sheri Lynn Hamersley, Thomas M Hyers, Vern Katz, Randall Kuhlmann, Edith A Nutescu, James A Thorp, James L Zehnder.   

Abstract

Venous thromboembolism and adverse pregnancy outcomes are potential complications of pregnancy. Numerous studies have evaluated both the risk factors for and the prevention and management of these outcomes in pregnant patients. This consensus group was convened to provide concise recommendations, based on the currently available literature, regarding the use of antithrombotic therapy in pregnant patients at risk for venous thromboembolic events and adverse pregnancy outcomes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17980177     DOI: 10.1016/j.ajog.2007.04.022

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  26 in total

1.  Genetic analysis of patients with deep vein thrombosis during pregnancy and postpartum.

Authors:  Reiko Neki; Tomio Fujita; Koichi Kokame; Isao Nakanishi; Masako Waguri; Yuzo Imayoshi; Noriyuki Suehara; Tomoaki Ikeda; Toshiyuki Miyata
Journal:  Int J Hematol       Date:  2011-08-03       Impact factor: 2.490

Review 2.  Role of thrombophilia testing: con.

Authors:  Scott M Stevens
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

3.  A systematic review on the use of new anticoagulants in pregnancy.

Authors:  Ai-Wei Tang; Ian Greer
Journal:  Obstet Med       Date:  2013-05-03

4.  Effect of enoxaparin on peak and trough levels of antifactor Xa in patients with a creatinine clearance of less than 30 mL/min.

Authors:  Ashish Anil Sule; Jam Chin Tay; Earnest Arul
Journal:  Int J Angiol       Date:  2009

Review 5.  Super obesity in pregnancy: difficulties in clinical management.

Authors:  A Martin; I Krishna; J Ellis; R Paccione; M Badell
Journal:  J Perinatol       Date:  2014-02-06       Impact factor: 2.521

6.  Antithrombin deficiency in pregnancy.

Authors:  Shivani Durai; Lay Kok Tan; Serene Lim
Journal:  BMJ Case Rep       Date:  2016-05-20

7.  Increased unfractionated heparin requirements with decreasing body mass index in pregnancy.

Authors:  Avinash S Patil; Tracy Clapp; Piyamas K Gaston; David Kuhl; Eliza Rinehart; Norman L Meyer
Journal:  Obstet Med       Date:  2016-08-04

8.  Dosing and monitoring of low-molecular-weight heparin in high-risk pregnancy: single-center experience.

Authors:  Nancy L Shapiro; Michelle A Kominiarek; Edith A Nutescu; Aimee B Chevalier; Judith U Hibbard
Journal:  Pharmacotherapy       Date:  2011-07       Impact factor: 4.705

Review 9.  The diagnosis and treatment of hypertensive disorders of pregnancy: new findings for antenatal and inpatient care.

Authors:  Werner Rath; Thorsten Fischer
Journal:  Dtsch Arztebl Int       Date:  2009-11-06       Impact factor: 5.594

10.  A randomized controlled trial of differing doses of postcesarean enoxaparin thromboprophylaxis in obese women.

Authors:  M L Stephenson; A E Serra; J M Neeper; D C Caballero; J McNulty
Journal:  J Perinatol       Date:  2015-12-10       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.